Saudi Central Bank’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.1M Buy
976,902
+188,320
+24% +$4.93M 0.32% 64
2026
Q1
$22.1M Buy
788,582
+207,514
+36% +$5.52M 0.47% 48
2025
Q4
$14.5M Buy
581,068
+5
+0% +$126 0.54% 36
2025
Q3
$14.8M Buy
581,063
+14
+0% +$346 0.56% 36
2025
Q2
$14.1M Buy
581,049
+578,819
+25,956% +$13.5M 0.57% 35
2025
Q1
$56.5K Buy
+2,230
New +$58.4K 0.3% 61

Other funds holding PFE

Saudi Central Bank's PFE Position: Q2 2026 in Review

Saudi Central Bank increased its Pfizer (PFE) stake by 24% in Q2 2026, buying an estimated $4.93M and bringing the position to 976,902 shares worth $24.1M. The position accounts for 0.32% of the portfolio, ranked #64.

Saudi Central Bank first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. 1,208 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Saudi Central Bank held 976,902 shares of Pfizer worth $24.1M as of Q2 2026.
  • Saudi Central Bank bought 188,320 Pfizer shares in Q2 2026, an estimated $4.93M.
  • Pfizer made up 0.32% of Saudi Central Bank's portfolio in Q2 2026, its #64 holding.
  • Saudi Central Bank first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • 1,208 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Saudi Central Bank's 13F filing for Q2 2026, filed 30 Jul 2026.